ACOR - Acorda Therapeu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (1.47%) UGAZ (%) VXX (-1.31%) BABA (3.24%) DFFN (-6%) NVDA (-0.33%) SPY (0.18%) MARA (0%) MA (1.05%) JNPR (-0.99%) JNCE (-3.74%) JAKK (-2.92%) ISRG (-0.27%) IPI (-1.83%) HD (-0.52%) GOOGL (0.61%) GME (-0.47%) EXPR (27.88%) ETSY (-2.54%) EOSUSD (%) DPW (-3.19%) DCPH (-0.91%) CGIX (-28.45%) BNGO (19.13%) BBBY (-2.5%)

5% or more down

ACOR - Acorda Therapeutics

$1.70 -0.13[%]

15 mins delayed data

People also watch : MNTA | BMRN | MYL | RGEN

+Watchlist

1 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$1.83	Open	$1.83
Volume	1.2M	Market Cap	451.17M
Yield		Last Dividend

Day

52 Week

Acorda (ACOR) Down 13.5% Since Last Earn...	12/04/19
Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Acorda (ACOR) Down More Than 80% Year to...	12/02/19
Acorda's (ACOR) lead MS drug Ampyra is hit by generic competition in the United States, which is hurting the company's top line of late. Parki...

Acorda Therapeutics Elects John Kelley C...	11/27/19
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that its Board of Directors has elected John Kelley to serve as non-executive board Chair, ef...

ANALYST RATINGS

3 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	08/14/19
H.C. Wainwright downgrades from Buy to Neutral rating and lowers Price Target from $31.00 to $6.00

Hold rating	08/02/19
and lowers Price Target from $8.00 to $7.00

Hold rating	08/02/19
Stifel maintains Hold rating and lowers Price Target from $12.00 to $7.00

EARNINGS

Date	2019-11-04 (AMC)	Est. (EPS/Rev.)	($0.61)/ 43.82M
Actual (EPS/Rev.)	$-0.46/ $47.72 M	EPS (TTM)	0

TRADERS TRACKING $ACOR

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%